Michael A Baumann

Title: Michael A. Baumann: Innovator in Synthetic Peptide Technology

Introduction

Michael A. Baumann is a notable inventor based in Baltimore, MD (US), recognized for his contributions to the field of synthetic peptides. With a total of 5 patents, his work focuses on innovative solutions for binding immune complexes and aggregated immunoglobulins.

Latest Patents

One of his latest patents is titled "Synthetic peptide and its uses." This invention provides a fragment of C1q characterized by its ability to selectively bind immune complexes or aggregated immunoglobulins in the presence of monomeric immunoglobulin. The invention also includes a synthetic peptide comprising a specific sequence or variants capable of binding immunoglobulin. These peptides are designed to effectively remove immune complexes and aggregated immunoglobulins from fluids containing monomeric immunoglobulin, as well as to detect or quantify immune complexes in such fluids. Additionally, the invention offers a binding material that comprises multiple binding peptides, which selectively bind immune complexes and aggregated immunoglobulins.

Career Highlights

Michael A. Baumann is affiliated with Northwestern University, where he continues to advance his research and innovation in synthetic peptide technology. His work has significant implications for medical and scientific applications, particularly in immunology.

Collaborations

Throughout his career, Baumann has collaborated with esteemed colleagues, including Byron E. Anderson and Jonathan P. Fryer, contributing to a rich environment of innovation and discovery.

Conclusion

Michael A. Baumann's contributions to synthetic peptide technology exemplify the impact of innovative research in the field of immunology. His patents and collaborations highlight the importance of scientific advancement in addressing complex medical challenges.